These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23998773)

  • 1. Health promotion and prevention strategies.
    Bradbury-Golas K
    Nurs Clin North Am; 2013 Sep; 48(3):469-83, vii. PubMed ID: 23998773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
    Lubman D; Koutsogiannis Z; Kronborg I
    Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Opiate substitution programs: last chance programs or deal for quality of life?].
    Manghi R; Soulignac R; Zullino D
    Rev Med Suisse; 2013 Sep; 9(398):1669-71. PubMed ID: 24164016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of health-related quality of life of opiate users at entry to low-threshold methadone programs.
    Millson P; Challacombe L; Villeneuve PJ; Strike CJ; Fischer B; Myers T; Shore R; Hopkins S
    Eur Addict Res; 2006; 12(2):74-82. PubMed ID: 16543742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction.
    Hallinan R; Byrne A; Dore GJ
    Drug Alcohol Rev; 2007 Jul; 26(4):437-43. PubMed ID: 17564882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical mismanagement in public methadone programs.
    Blansfield HN
    Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategies for maintenance of health-promoting behaviors.
    Redland AR; Stuifbergen AK
    Nurs Clin North Am; 1993 Jun; 28(2):427-42. PubMed ID: 8516183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the neurobiology, assessment, and treatment of substances of abuse and dependence: a guide for the critical care nurse.
    Genung V
    Crit Care Nurs Clin North Am; 2012 Mar; 24(1):117-30. PubMed ID: 22405717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants.
    Disney E; Kidorf M; Kolodner K; King V; Peirce J; Beilenson P; Brooner RK
    J Nerv Ment Dis; 2006 Aug; 194(8):577-83. PubMed ID: 16909065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A health promotion programme in Adventist and non-Adventist women based on Pender's model: a pilot study.
    Carreño J; Vyhmeister G; Grau L; Ivanovic D
    Public Health; 2006 Apr; 120(4):346-55. PubMed ID: 16476453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rights of drug treatment patients: Experience of addiction treatment in Poland from a human rights perspective.
    Klingemann J
    Int J Drug Policy; 2017 May; 43():67-73. PubMed ID: 28231439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenting and early development among children of drug-abusing women: effects of home intervention.
    Black MM; Nair P; Kight C; Wachtel R; Roby P; Schuler M
    Pediatrics; 1994 Oct; 94(4 Pt 1):440-8. PubMed ID: 7936850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid dependent patients' experiences of and attitudes towards having their injecting sites examined.
    Winstock AR; Nittis M; Whitton G; Lea T
    Int J Drug Policy; 2009 Jan; 20(1):85-9. PubMed ID: 18164193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbid posttraumatic stress disorder and opiate addiction: a literature review.
    Fareed A; Eilender P; Haber M; Bremner J; Whitfield N; Drexler K
    J Addict Dis; 2013; 32(2):168-79. PubMed ID: 23815424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personality differences between drug injectors and non-injectors among substance-dependent patients in substitution treatment.
    Saint-Lèbes J; Rodgers R; Birmes P; Schmitt L
    Am J Drug Alcohol Abuse; 2012 Mar; 38(2):135-9. PubMed ID: 22220585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bulimia in opiate-addicted women: developmental cousin and relapse factor.
    Katzman MA; Greenberg A; Marcus ID
    J Subst Abuse Treat; 1991; 8(3):107-12. PubMed ID: 1960764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug consumption facility as part of a primary health care centre for problem drug users - which clients are attracted?
    Scherbaum N; Specka M; Bombeck J; Marrziniak B
    Int J Drug Policy; 2009 Sep; 20(5):447-9. PubMed ID: 19269803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate addiction in China: current situation and treatments.
    Tang YL; Zhao D; Zhao C; Cubells JF
    Addiction; 2006 May; 101(5):657-65. PubMed ID: 16669899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.